Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Milne

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2004
ISPOR's "Code of Ethics for Researchers": is it ethical?Richard J Milne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization scheduleRichard J Milne, Keith Grimwood
The New Zealand Medical Journal|February 10, 2015
Hospital admissions for chronic obstructive pulmonary disease in New ZealandRichard J Milne, Richard Beasley
Applied Health Economics and Health Policy|September 1, 2010
Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New ZealandRichard J Milne, Stephen Vander Hoorn
Pain|October 1, 1989
Habituation to sham testing procedures modifies tail-flick latencies: effects on nociception rather than vasomotor toneRichard J Milne, Gregory D Gamble
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
Discounting health outcomes in economic evaluation: the ongoing debateJohan L Severens, Richard J Milne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasisRichard J Milne, Hans Hockey, Harry Rea
British Journal of Haematology|October 5, 2019
Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New ZealandHenry S H Chan, Richard J Milne
International Journal of Chronic Obstructive Pulmonary Disease|June 10, 2022
Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow TherapyRichard J Milne, Hans-Ulrich Hockey, Jeffrey Garrett
Paediatric Drugs|July 3, 2010
Rotavirus infections and vaccines: burden of illness and potential impact of vaccinationKeith Grimwood, Stephen B Lambert, Richard J Milne
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2004
ISPOR's "Code of Ethics for Researchers": is it ethical?Richard J Milne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization scheduleRichard J Milne, Keith Grimwood
The New Zealand Medical Journal|February 10, 2015
Hospital admissions for chronic obstructive pulmonary disease in New ZealandRichard J Milne, Richard Beasley
Applied Health Economics and Health Policy|September 1, 2010
Burden and cost of hospital admissions for vaccine-preventable paediatric pneumococcal disease and non-typable Haemophilus influenzae otitis media in New ZealandRichard J Milne, Stephen Vander Hoorn
Pain|October 1, 1989
Habituation to sham testing procedures modifies tail-flick latencies: effects on nociception rather than vasomotor toneRichard J Milne, Gregory D Gamble
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
Discounting health outcomes in economic evaluation: the ongoing debateJohan L Severens, Richard J Milne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasisRichard J Milne, Hans Hockey, Harry Rea
British Journal of Haematology|October 5, 2019
Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New ZealandHenry S H Chan, Richard J Milne
International Journal of Chronic Obstructive Pulmonary Disease|June 10, 2022
Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow TherapyRichard J Milne, Hans-Ulrich Hockey, Jeffrey Garrett
Paediatric Drugs|July 3, 2010
Rotavirus infections and vaccines: burden of illness and potential impact of vaccinationKeith Grimwood, Stephen B Lambert, Richard J Milne
Pageof 2